MYTELMI AM TAB

About

MYTELMI AM TAB is a combination medication primarily used for the treatment of essential hypertension (high blood pressure). It typically contains Telmisartan and Amlodipine. Telmisartan is an angiotensin II receptor blocker (ARB) that works by blocking the action of angiotensin II, a potent vasoconstrictor. This leads to relaxation of blood vessels, reducing blood pressure and improving blood flow. It also offers protective effects on the kidneys and heart.

Amlodipine is a dihydropyridine calcium channel blocker that relaxes the smooth muscles in the walls of blood vessels, causing them to widen. This reduces peripheral vascular resistance and lowers blood pressure. Amlodipine also helps to reduce the workload on the heart. The combination of these two agents provides a comprehensive and effective approach to blood pressure control, often leading to better outcomes than monotherapy and reducing the risk of cardiovascular events.

Uses

• Treatment of essential hypertension
• Management of high blood pressure
• Reduction of cardiovascular risk
• Prevention of stroke and heart attack

Directions For Use

Take one tablet once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Provides effective and sustained blood pressure control
• Reduces the risk of major cardiovascular events
• Offers protective benefits for the heart and kidneys
• Improves blood flow by relaxing blood vessels
• Helps prevent complications associated with hypertension
• Convenient once-daily dosing for better adherence

Side Effects

• Dizziness
• Headache
• Ankle swelling (edema)
• Fatigue
• Flushing
• Nausea
• Abdominal pain
• Palpitations
• Cough
• Muscle cramps
• Orthostatic hypotension
• Bradycardia

Safety Measures

• Alcohol - Avoid excessive alcohol consumption while taking this medication, as it can further lower blood pressure and increase the risk of dizziness and lightheadedness.
• Pregnancy - This medication is contraindicated in the second and third trimesters of pregnancy due to the risk of fetal harm (Telmisartan). Consult your doctor immediately if you become pregnant.
• Breastfeeding - Not recommended during breastfeeding, as both Telmisartan and Amlodipine can pass into breast milk. Consult your doctor for safer alternatives.
• Liver - Use with caution in patients with liver conditions. Dose adjustment may be necessary, especially with Telmisartan, as it is primarily metabolized by the liver.
• Kidney - Use with caution in patients with kidney conditions. Monitor kidney function regularly, especially with Telmisartan, as it can affect renal hemodynamics.
• Lung - Generally safe for use in patients with lung conditions. However, Amlodipine can rarely cause pulmonary edema in susceptible individuals.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.